Selected research
Market Analysis & Forecast
Global Colchicine Market Analysis and Forecast 2026-2032
Market perspective
The global Colchicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Colchicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Colchicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Colchicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Colchicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Colchicine include Yunnan Plant Medicine, Xishuangbanna Pharmaceutical, Takeda Pharmaceuticals, Tonghua Limin, Kunming Pharmaceutical, Beijing Jialin Pharmaceutical, Yunnan Shan State, Wockhardt and West-Ward, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Colchicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Colchicine, also provides the sales of main regions and countries. Of the upcoming market potential for Colchicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Colchicine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Colchicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Colchicine sales, projected growth trends, production technology, application and end-user industry.
Colchicine Segment by Company
Yunnan Plant Medicine
Xishuangbanna Pharmaceutical
Takeda Pharmaceuticals
Tonghua Limin
Kunming Pharmaceutical
Beijing Jialin Pharmaceutical
Yunnan Shan State
Wockhardt
West-Ward
Rhea Pharmaceutical
Prasco
Odan Laboratories
Medinova
Hikma
Guangdong Pedi
Excellium Pharmaceutical
Cipla
Colchicine Segment by Type
Tablet
Oral Solution
Colchicine Segment by Application
Acute Gout
Chronic Gout
Other Conditions
Colchicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colchicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colchicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colchicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Colchicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Colchicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Colchicine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Oral Solution
Applications
- Acute Gout
- Chronic Gout
- Other Conditions
Companies covered
- Yunnan Plant Medicine
- Xishuangbanna Pharmaceutical
- Takeda Pharmaceuticals
- Tonghua Limin
- Kunming Pharmaceutical
- Beijing Jialin Pharmaceutical
- Yunnan Shan State
- Wockhardt
- West-Ward
- Rhea Pharmaceutical
- Prasco
- Odan Laboratories
- Medinova
- Hikma
- Guangdong Pedi
- Excellium Pharmaceutical
- Cipla
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Colchicine Market by Type
- 1.2.1 Global Colchicine Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Tablet
- 1.2.3 Oral Solution
- 1.3 Colchicine Market by Application
- 1.3.1 Global Colchicine Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Acute Gout
- 1.3.3 Chronic Gout
- 1.3.4 Other Conditions
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Colchicine Market Dynamics
- 2.1 Colchicine Industry Trends
- 2.2 Colchicine Industry Drivers
- 2.3 Colchicine Industry Opportunities and Challenges
- 2.4 Colchicine Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Colchicine Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Colchicine Revenue by Region
- 3.2.1 Global Colchicine Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Colchicine Revenue by Region (2021-2026)
- 3.2.3 Global Colchicine Revenue by Region (2027-2032)
- 3.2.4 Global Colchicine Revenue Market Share by Region (2021-2032)
- 3.3 Global Colchicine Sales Estimates and Forecasts 2021-2032
- 3.4 Global Colchicine Sales by Region
- 3.4.1 Global Colchicine Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Colchicine Sales by Region (2021-2026)
- 3.4.3 Global Colchicine Sales by Region (2027-2032)
- 3.4.4 Global Colchicine Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Colchicine Revenue by Manufacturers
- 4.1.1 Global Colchicine Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Colchicine Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Colchicine Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Colchicine Sales by Manufacturers
- 4.2.1 Global Colchicine Sales by Manufacturers (2021-2026)
- 4.2.2 Global Colchicine Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Colchicine Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Colchicine Sales Price by Manufacturers (2021-2026)
- 4.4 Global Colchicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Colchicine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Colchicine Manufacturers, Product Type & Application
- 4.7 Global Colchicine Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Colchicine Market CR5 and HHI
- 4.8.2 2025 Colchicine Tier 1, Tier 2, and Tier 3
5 Colchicine Market by Type
- 5.1 Global Colchicine Revenue by Type
- 5.1.1 Global Colchicine Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Colchicine Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Colchicine Revenue Market Share by Type (2021-2032)
- 5.2 Global Colchicine Sales by Type
- 5.2.1 Global Colchicine Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Colchicine Sales by Type (2021-2032) & (tons)
- 5.2.3 Global Colchicine Sales Market Share by Type (2021-2032)
- 5.3 Global Colchicine Price by Type
6 Colchicine Market by Application
- 6.1 Global Colchicine Revenue by Application
- 6.1.1 Global Colchicine Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Colchicine Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Colchicine Revenue Market Share by Application (2021-2032)
- 6.2 Global Colchicine Sales by Application
- 6.2.1 Global Colchicine Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Colchicine Sales by Application (2021-2032) & (tons)
- 6.2.3 Global Colchicine Sales Market Share by Application (2021-2032)
- 6.3 Global Colchicine Price by Application
7 Company Profiles
- 7.1 Yunnan Plant Medicine
- 7.1.1 Yunnan Plant Medicine Company Information
- 7.1.2 Yunnan Plant Medicine Business Overview
- 7.1.3 Yunnan Plant Medicine Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Yunnan Plant Medicine Colchicine Product Portfolio
- 7.1.5 Yunnan Plant Medicine Recent Developments
- 7.2 Xishuangbanna Pharmaceutical
- 7.2.1 Xishuangbanna Pharmaceutical Company Information
- 7.2.2 Xishuangbanna Pharmaceutical Business Overview
- 7.2.3 Xishuangbanna Pharmaceutical Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Xishuangbanna Pharmaceutical Colchicine Product Portfolio
- 7.2.5 Xishuangbanna Pharmaceutical Recent Developments
- 7.3 Takeda Pharmaceuticals
- 7.3.1 Takeda Pharmaceuticals Company Information
- 7.3.2 Takeda Pharmaceuticals Business Overview
- 7.3.3 Takeda Pharmaceuticals Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Takeda Pharmaceuticals Colchicine Product Portfolio
- 7.3.5 Takeda Pharmaceuticals Recent Developments
- 7.4 Tonghua Limin
- 7.4.1 Tonghua Limin Company Information
- 7.4.2 Tonghua Limin Business Overview
- 7.4.3 Tonghua Limin Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Tonghua Limin Colchicine Product Portfolio
- 7.4.5 Tonghua Limin Recent Developments
- 7.5 Kunming Pharmaceutical
- 7.5.1 Kunming Pharmaceutical Company Information
- 7.5.2 Kunming Pharmaceutical Business Overview
- 7.5.3 Kunming Pharmaceutical Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Kunming Pharmaceutical Colchicine Product Portfolio
- 7.5.5 Kunming Pharmaceutical Recent Developments
- 7.6 Beijing Jialin Pharmaceutical
- 7.6.1 Beijing Jialin Pharmaceutical Company Information
- 7.6.2 Beijing Jialin Pharmaceutical Business Overview
- 7.6.3 Beijing Jialin Pharmaceutical Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Beijing Jialin Pharmaceutical Colchicine Product Portfolio
- 7.6.5 Beijing Jialin Pharmaceutical Recent Developments
- 7.7 Yunnan Shan State
- 7.7.1 Yunnan Shan State Company Information
- 7.7.2 Yunnan Shan State Business Overview
- 7.7.3 Yunnan Shan State Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Yunnan Shan State Colchicine Product Portfolio
- 7.7.5 Yunnan Shan State Recent Developments
- 7.8 Wockhardt
- 7.8.1 Wockhardt Company Information
- 7.8.2 Wockhardt Business Overview
- 7.8.3 Wockhardt Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Wockhardt Colchicine Product Portfolio
- 7.8.5 Wockhardt Recent Developments
- 7.9 West-Ward
- 7.9.1 West-Ward Company Information
- 7.9.2 West-Ward Business Overview
- 7.9.3 West-Ward Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 West-Ward Colchicine Product Portfolio
- 7.9.5 West-Ward Recent Developments
- 7.10 Rhea Pharmaceutical
- 7.10.1 Rhea Pharmaceutical Company Information
- 7.10.2 Rhea Pharmaceutical Business Overview
- 7.10.3 Rhea Pharmaceutical Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Rhea Pharmaceutical Colchicine Product Portfolio
- 7.10.5 Rhea Pharmaceutical Recent Developments
- 7.11 Prasco
- 7.11.1 Prasco Company Information
- 7.11.2 Prasco Business Overview
- 7.11.3 Prasco Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Prasco Colchicine Product Portfolio
- 7.11.5 Prasco Recent Developments
- 7.12 Odan Laboratories
- 7.12.1 Odan Laboratories Company Information
- 7.12.2 Odan Laboratories Business Overview
- 7.12.3 Odan Laboratories Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Odan Laboratories Colchicine Product Portfolio
- 7.12.5 Odan Laboratories Recent Developments
- 7.13 Medinova
- 7.13.1 Medinova Company Information
- 7.13.2 Medinova Business Overview
- 7.13.3 Medinova Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Medinova Colchicine Product Portfolio
- 7.13.5 Medinova Recent Developments
- 7.14 Hikma
- 7.14.1 Hikma Company Information
- 7.14.2 Hikma Business Overview
- 7.14.3 Hikma Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Hikma Colchicine Product Portfolio
- 7.14.5 Hikma Recent Developments
- 7.15 Guangdong Pedi
- 7.15.1 Guangdong Pedi Company Information
- 7.15.2 Guangdong Pedi Business Overview
- 7.15.3 Guangdong Pedi Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Guangdong Pedi Colchicine Product Portfolio
- 7.15.5 Guangdong Pedi Recent Developments
- 7.16 Excellium Pharmaceutical
- 7.16.1 Excellium Pharmaceutical Company Information
- 7.16.2 Excellium Pharmaceutical Business Overview
- 7.16.3 Excellium Pharmaceutical Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.16.4 Excellium Pharmaceutical Colchicine Product Portfolio
- 7.16.5 Excellium Pharmaceutical Recent Developments
- 7.17 Cipla
- 7.17.1 Cipla Company Information
- 7.17.2 Cipla Business Overview
- 7.17.3 Cipla Colchicine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.17.4 Cipla Colchicine Product Portfolio
- 7.17.5 Cipla Recent Developments
8 North America
- 8.1 North America Colchicine Market Size by Type
- 8.1.1 North America Colchicine Revenue by Type (2021-2032)
- 8.1.2 North America Colchicine Sales by Type (2021-2032)
- 8.1.3 North America Colchicine Price by Type (2021-2032)
- 8.2 North America Colchicine Market Size by Application
- 8.2.1 North America Colchicine Revenue by Application (2021-2032)
- 8.2.2 North America Colchicine Sales by Application (2021-2032)
- 8.2.3 North America Colchicine Price by Application (2021-2032)
- 8.3 North America Colchicine Market Size by Country
- 8.3.1 North America Colchicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Colchicine Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Colchicine Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Colchicine Market Size by Type
- 9.1.1 Europe Colchicine Revenue by Type (2021-2032)
- 9.1.2 Europe Colchicine Sales by Type (2021-2032)
- 9.1.3 Europe Colchicine Price by Type (2021-2032)
- 9.2 Europe Colchicine Market Size by Application
- 9.2.1 Europe Colchicine Revenue by Application (2021-2032)
- 9.2.2 Europe Colchicine Sales by Application (2021-2032)
- 9.2.3 Europe Colchicine Price by Application (2021-2032)
- 9.3 Europe Colchicine Market Size by Country
- 9.3.1 Europe Colchicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Colchicine Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Colchicine Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Colchicine Market Size by Type
- 10.1.1 China Colchicine Revenue by Type (2021-2032)
- 10.1.2 China Colchicine Sales by Type (2021-2032)
- 10.1.3 China Colchicine Price by Type (2021-2032)
- 10.2 China Colchicine Market Size by Application
- 10.2.1 China Colchicine Revenue by Application (2021-2032)
- 10.2.2 China Colchicine Sales by Application (2021-2032)
- 10.2.3 China Colchicine Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Colchicine Market Size by Type
- 11.1.1 Asia Colchicine Revenue by Type (2021-2032)
- 11.1.2 Asia Colchicine Sales by Type (2021-2032)
- 11.1.3 Asia Colchicine Price by Type (2021-2032)
- 11.2 Asia Colchicine Market Size by Application
- 11.2.1 Asia Colchicine Revenue by Application (2021-2032)
- 11.2.2 Asia Colchicine Sales by Application (2021-2032)
- 11.2.3 Asia Colchicine Price by Application (2021-2032)
- 11.3 Asia Colchicine Market Size by Country
- 11.3.1 Asia Colchicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Colchicine Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Colchicine Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Colchicine Market Size by Type
- 12.1.1 SAMEA Colchicine Revenue by Type (2021-2032)
- 12.1.2 SAMEA Colchicine Sales by Type (2021-2032)
- 12.1.3 SAMEA Colchicine Price by Type (2021-2032)
- 12.2 SAMEA Colchicine Market Size by Application
- 12.2.1 SAMEA Colchicine Revenue by Application (2021-2032)
- 12.2.2 SAMEA Colchicine Sales by Application (2021-2032)
- 12.2.3 SAMEA Colchicine Price by Application (2021-2032)
- 12.3 SAMEA Colchicine Market Size by Country
- 12.3.1 SAMEA Colchicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Colchicine Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Colchicine Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Colchicine Value Chain Analysis
- 13.1.1 Colchicine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Colchicine Production Mode & Process
- 13.2 Colchicine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Colchicine Distributors
- 13.2.3 Colchicine Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst